Canada markets close in 3 minutes

Inovio Pharmaceuticals, Inc. (INO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
11.00+0.04 (+0.36%)
At close: 04:00PM EDT
10.94 -0.06 (-0.55%)
After hours: 06:31PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 285.02M
Enterprise Value 192.83M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)346.88
Price/Book (mrq)3.02
Enterprise Value/Revenue 268.91
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 355.37%
S&P500 52-Week Change 326.14%
52 Week High 314.75
52 Week Low 33.84
50-Day Moving Average 311.39
200-Day Moving Average 37.37

Share Statistics

Avg Vol (3 month) 3436.11k
Avg Vol (10 day) 3390.87k
Shares Outstanding 525.91M
Implied Shares Outstanding 625.91M
Float 825.53M
% Held by Insiders 11.59%
% Held by Institutions 117.60%
Shares Short (Apr 30, 2024) 42.03M
Short Ratio (Apr 30, 2024) 45.6
Short % of Float (Apr 30, 2024) 47.89%
Short % of Shares Outstanding (Apr 30, 2024) 47.83%
Shares Short (prior month Mar 28, 2024) 42.1M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Jan 25, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-16,868.64%

Management Effectiveness

Return on Assets (ttm)-38.21%
Return on Equity (ttm)-85.09%

Income Statement

Revenue (ttm)717.07k
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -118.56M
Net Income Avi to Common (ttm)-124.94M
Diluted EPS (ttm)-5.51
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)105.61M
Total Cash Per Share (mrq)4.08
Total Debt (mrq)13.43M
Total Debt/Equity (mrq)14.22%
Current Ratio (mrq)4.77
Book Value Per Share (mrq)3.64

Cash Flow Statement

Operating Cash Flow (ttm)-116.46M
Levered Free Cash Flow (ttm)-73.01M